Patents by Inventor Gary Beaudry

Gary Beaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the diagnosis and treatment of lung cancer
    Patent number: 8067240
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: November 29, 2011
    Assignees: Esoterix Genetic Laboratories, LLC, Johns Hopkins University School of Medicine
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Methods for the Diagnosis and Treatment of Lung Cancer
    Publication number: 20110091892
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: November 22, 2010
    Publication date: April 21, 2011
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Methods for the diagnosis and treatment of lung cancer
    Patent number: 7846667
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Grant
    Filed: August 20, 2009
    Date of Patent: December 7, 2010
    Assignees: Genzyme Corporation, Johns Hopkins University
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Methods for the Diagnosis and Treatment of Lung Cancer
    Publication number: 20100062443
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: August 20, 2009
    Publication date: March 11, 2010
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Methods for the diagnosis and treatment of lung cancer
    Publication number: 20070218511
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell, and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: August 14, 2006
    Publication date: September 20, 2007
    Inventors: Jin Jen, Gary Beaudry, Stephen Madden, Arthur Bertlesen, David Sidransky
  • Cells expressing a CD4-IgG2 chimeric heterotetramer
    Patent number: 7070991
    Abstract: This invention provides an expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer. This invention also provides an expression vector encoding the heavy chains of a CD4-IgG2 chimeric heterotetramer. Finally, this invention provides an expression vector encoding the light chains of a CD4-IgG2 chimeric heterotetramer.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 4, 2006
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Gary A. Beaudry, Paul J. Maddon
  • Compositions and methods for the identification of lung tumor cells
    Publication number: 20040166527
    Abstract: This invention provides compositions and methods for the identification of lung cancer cells. In particular, polynucleotide sequences whose presence is indicative of lung cancer are disclosed. In addition, lung cancer can be identified by detecting the presence of the peptides encoded by these sequences. Antibodies to these peptides are also provided. Also included are gene delivery vehicles and host cells comprising these polynucleotides. Kits containing agents and instructions necessary to perform the screening and detecting methods are also provided.
    Type: Application
    Filed: April 1, 2004
    Publication date: August 26, 2004
    Inventors: Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertelsen
  • CD4-gamma2 and CD4-IGG2 chimeras
    Patent number: 6451313
    Abstract: This invention provides an expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer. This invention also provides an expression vector encoding the heavy chains of a CD4-IgG2 chimeric heterotetramer. Finally, this invention provides an expression vector encoding the light chains of a CD4-IgG2 chimeric heterotetramer.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 17, 2002
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Paul J. Maddon, Gary A. Beaudry
  • CD4-GAMMA2 AND CD4-IGG2 CHIMERAS
    Publication number: 20020098191
    Abstract: This invention provides an expression vector encoding a CD4-gamma2 chimeric heavy chain homodimer. This invention also provides an expression vector encoding the heavy chains of a CD4-IgG2 chimeric heterotetramer. Finally, this invention provides an expression vector encoding the light chains of a CD4-IgG2 chimeric heterotetramer.
    Type: Application
    Filed: June 7, 1995
    Publication date: July 25, 2002
    Inventors: GARY A. BEAUDRY, PAUL J. MADDON
  • Uses of CD4-gamma2 and CD4-IgG2 chimeras
    Patent number: 6187748
    Abstract: This invention provides the CD4-IgG2 chimeric heterotetramer, wherein the heavy chains of the chimeric heterotetramer is encoded by the expression vector designated CD4-IgG2HC-pRcCMV (ATCC No. 75193). This invention also provides the CD4-IgG2 chimeric heterotetramer, wherein the light chains of the chimeric heterotetramer is encoded by the expression vector designated CD4-kLC-pRcCMV (ATCC No. 75194). This invention also provides the CD4-IgG2 chimeric heterotetramer, wherein the heavy chains of the chimeric heterotetramer is encoded by the expression vector designated CD4-IgG2HC-pRcCMV (ATCC No. 75193) and the light chains of the chimeric heterotetramer is encoded by the expression vector designated CD4-kLC-pRcCMV (ATCC No. 75194).
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 13, 2001
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Paul J. Maddon, Gary A. Beaudry
  • Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby
    Patent number: 5700657
    Abstract: Vectors and vector systems are embodied that include a gene encoding a tumor suppressor protein. In one embodiment, the vector includes a gene encoding a tumor suppressor protein and an inducible promoter controlling the gene encoding a tumor suppressor protein. The tumor suppressor protein may be p53 protein. In another embodiment, there is provided a vector system which comprises a first vector including a gene encoding a tumor suppressor protein, and a second vector containing a nucleic acid sequence encoding an antisense sequence complementary to all or a portion of the gene encoding a tumor suppressor protein. In yet another embodiment, there is provided a vector system which comprises a first vector including a gene encoding a tumor suppressor protein, and a second vector containing a gene which encodes a protein which binds to, and thereby inhibits, the tumor suppressor protein.
    Type: Grant
    Filed: December 13, 1993
    Date of Patent: December 23, 1997
    Assignee: Genzyme Corporation
    Inventors: Gary A. Beaudry, Arthur H. Bertelsen, Michael I. Sherman, Bert Vogelstein